Abcellera Biologics Stock Price History
| ABCL Stock | USD 2.38 0.01 0.42% |
Below is the normalized historical share price chart for Abcellera Biologics extending back to December 11, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Abcellera Biologics stands at 2.38, as last reported on the 21st of March, with the highest price reaching 2.43 and the lowest price hitting 2.32 during the day.
If you're considering investing in Abcellera Stock, it is important to understand the factors that can impact its price. Abcellera Biologics secures Sharpe Ratio (or Efficiency) of -0.0511, which signifies that the company had a -0.0511 % return per unit of standard deviation over the last 3 months. Abcellera Biologics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Abcellera Biologics' risk adjusted performance of (0.03), and Mean Deviation of 3.53 to double-check the risk estimate we provide.
At this time, Abcellera Biologics' Common Stock Shares Outstanding is quite stable compared to the past year. Other Stockholder Equity is expected to rise to about 297.5 M this year, although the value of Common Stock Total Equity will most likely fall to about 479 M. . The value of Price To Sales Ratio is estimated to slide to 28.41. Price Earnings Ratio is expected to rise to -5.03 this year. Abcellera Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of December 2020 | 200 Day MA 2.8705 | 50 Day MA 2.9331 | Beta 0.452 |
Abcellera |
Sharpe Ratio = -0.0511
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ABCL |
Estimated Market Risk
| 4.67 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Abcellera Biologics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abcellera Biologics by adding Abcellera Biologics to a well-diversified portfolio.
Price Book 0.6744 | Enterprise Value Ebitda 5.3008 | Price Sales 24.7006 | Shares Float 202.8 M | Wall Street Target Price 11.8571 |
Abcellera Biologics Stock Price History Chart
There are several ways to analyze Abcellera Stock price data. The simplest method is using a basic Abcellera candlestick price chart, which shows Abcellera Biologics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 22, 2025 | 3.53 |
| Lowest Price | March 10, 2025 | 2.2 |
Abcellera Biologics March 21, 2025 Stock Price Synopsis
Various analyses of Abcellera Biologics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Abcellera Stock. It can be used to describe the percentage change in the price of Abcellera Biologics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Abcellera Stock.| Abcellera Biologics Price Rate Of Daily Change | 1.00 | |
| Abcellera Biologics Price Daily Balance Of Power | (0.09) |
Abcellera Biologics March 21, 2025 Stock Price Analysis
Abcellera Stock Price History Data
The price series of Abcellera Biologics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 1.33 with a coefficient of variation of 11.77. The prices are distributed with arithmetic mean of 2.92. The median price for the last 90 days is 2.96.| Open | High | Low | Close | Volume | ||
03/21/2025 | 2.39 | 2.43 | 2.32 | 2.38 | ||
| 03/19/2025 | 2.33 | 2.43 | 2.32 | 2.39 | 3,671,461 | |
| 03/18/2025 | 2.52 | 2.52 | 2.34 | 2.35 | 3,362,988 | |
| 03/17/2025 | 2.50 | 2.55 | 2.40 | 2.54 | 4,108,086 | |
| 03/14/2025 | 2.45 | 2.60 | 2.45 | 2.52 | 4,449,467 | |
| 03/13/2025 | 2.34 | 2.41 | 2.31 | 2.40 | 3,164,983 | |
| 03/12/2025 | 2.30 | 2.36 | 2.26 | 2.35 | 2,702,925 | |
| 03/11/2025 | 2.22 | 2.24 | 2.11 | 2.23 | 6,097,157 | |
| 03/10/2025 | 2.33 | 2.33 | 2.17 | 2.20 | 5,627,240 | |
| 03/07/2025 | 2.38 | 2.41 | 2.25 | 2.33 | 4,304,920 | |
| 03/06/2025 | 2.32 | 2.41 | 2.27 | 2.38 | 4,596,357 | |
| 03/05/2025 | 2.37 | 2.41 | 2.26 | 2.39 | 4,389,316 | |
| 03/04/2025 | 2.34 | 2.39 | 2.20 | 2.34 | 5,048,655 | |
| 03/03/2025 | 2.61 | 2.61 | 2.32 | 2.36 | 3,729,665 | |
| 02/28/2025 | 2.72 | 2.72 | 2.31 | 2.59 | 9,925,645 | |
| 02/27/2025 | 2.96 | 3.01 | 2.87 | 2.92 | 5,423,058 | |
| 02/26/2025 | 2.86 | 3.00 | 2.84 | 2.92 | 3,155,238 | |
| 02/25/2025 | 3.02 | 3.02 | 2.75 | 2.82 | 5,553,424 | |
| 02/24/2025 | 3.03 | 3.04 | 2.89 | 2.99 | 5,622,121 | |
| 02/21/2025 | 3.23 | 3.23 | 3.03 | 3.03 | 2,354,351 | |
| 02/20/2025 | 3.49 | 3.50 | 3.12 | 3.14 | 3,443,238 | |
| 02/19/2025 | 3.40 | 3.55 | 3.29 | 3.47 | 5,550,570 | |
| 02/18/2025 | 3.42 | 3.60 | 3.39 | 3.43 | 8,004,832 | |
| 02/14/2025 | 3.17 | 3.28 | 3.12 | 3.27 | 5,961,947 | |
| 02/13/2025 | 3.12 | 3.15 | 3.02 | 3.14 | 4,237,987 | |
| 02/12/2025 | 2.90 | 3.11 | 2.88 | 3.10 | 3,017,070 | |
| 02/11/2025 | 3.02 | 3.02 | 2.90 | 2.95 | 3,160,753 | |
| 02/10/2025 | 3.11 | 3.12 | 2.97 | 3.02 | 3,325,206 | |
| 02/07/2025 | 3.27 | 3.32 | 3.05 | 3.10 | 3,503,463 | |
| 02/06/2025 | 3.41 | 3.42 | 3.26 | 3.29 | 2,574,532 | |
| 02/05/2025 | 3.23 | 3.40 | 3.18 | 3.38 | 4,386,246 | |
| 02/04/2025 | 3.08 | 3.24 | 3.07 | 3.21 | 2,274,008 | |
| 02/03/2025 | 3.01 | 3.11 | 2.96 | 3.08 | 4,505,673 | |
| 01/31/2025 | 3.26 | 3.32 | 3.13 | 3.17 | 3,081,877 | |
| 01/30/2025 | 3.25 | 3.31 | 3.19 | 3.23 | 2,193,494 | |
| 01/29/2025 | 3.33 | 3.36 | 3.15 | 3.20 | 4,077,116 | |
| 01/28/2025 | 3.35 | 3.38 | 3.17 | 3.30 | 3,033,434 | |
| 01/27/2025 | 3.38 | 3.46 | 3.27 | 3.36 | 4,051,043 | |
| 01/24/2025 | 3.56 | 3.61 | 3.44 | 3.48 | 4,489,688 | |
| 01/23/2025 | 3.49 | 3.56 | 3.34 | 3.52 | 3,918,301 | |
| 01/22/2025 | 3.10 | 3.68 | 3.06 | 3.53 | 11,032,560 | |
| 01/21/2025 | 3.00 | 3.14 | 2.96 | 3.06 | 3,697,087 | |
| 01/17/2025 | 2.95 | 3.00 | 2.92 | 2.97 | 1,566,453 | |
| 01/16/2025 | 2.97 | 3.00 | 2.81 | 2.94 | 2,994,263 | |
| 01/15/2025 | 2.85 | 3.09 | 2.85 | 2.96 | 4,444,804 | |
| 01/14/2025 | 3.04 | 3.07 | 2.76 | 2.77 | 5,688,452 | |
| 01/13/2025 | 2.98 | 3.01 | 2.81 | 3.00 | 4,142,688 | |
| 01/10/2025 | 2.98 | 2.99 | 2.87 | 2.92 | 3,363,170 | |
| 01/08/2025 | 3.26 | 3.27 | 2.96 | 3.03 | 3,607,921 | |
| 01/07/2025 | 3.41 | 3.47 | 3.26 | 3.28 | 4,019,485 | |
| 01/06/2025 | 3.20 | 3.43 | 3.14 | 3.31 | 4,585,225 | |
| 01/03/2025 | 3.05 | 3.17 | 3.03 | 3.13 | 2,582,685 | |
| 01/02/2025 | 2.96 | 3.15 | 2.93 | 3.03 | 2,639,326 | |
| 12/31/2024 | 2.81 | 2.95 | 2.81 | 2.93 | 1,862,585 | |
| 12/30/2024 | 2.95 | 2.96 | 2.79 | 2.82 | 3,283,375 | |
| 12/27/2024 | 3.01 | 3.06 | 2.87 | 2.99 | 3,384,100 | |
| 12/26/2024 | 2.90 | 3.07 | 2.89 | 3.03 | 2,988,549 | |
| 12/24/2024 | 2.93 | 2.96 | 2.85 | 2.95 | 1,649,055 | |
| 12/23/2024 | 2.82 | 2.95 | 2.82 | 2.92 | 2,085,481 | |
| 12/20/2024 | 2.70 | 2.88 | 2.68 | 2.85 | 2,082,873 | |
| 12/19/2024 | 2.71 | 2.75 | 2.62 | 2.71 | 2,359,432 |
About Abcellera Biologics Stock history
Abcellera Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Abcellera is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Abcellera Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Abcellera Biologics stock prices may prove useful in developing a viable investing in Abcellera Biologics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 294.3 M | 295.1 M | |
| Net Income Applicable To Common Shares | 182.3 M | 94.4 M |
Abcellera Biologics Quarterly Net Working Capital |
|
Abcellera Biologics Stock Technical Analysis
Abcellera Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Abcellera Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Abcellera Biologics' price direction in advance. Along with the technical and fundamental analysis of Abcellera Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Abcellera to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | 0.1784 | |||
| Treynor Ratio | (0.13) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera Biologics. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.55) | Revenue Per Share | Quarterly Revenue Growth (0.45) | Return On Assets |
The market value of Abcellera Biologics is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera Biologics' value that differs from its market value or its book value, called intrinsic value, which is Abcellera Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera Biologics' market value can be influenced by many factors that don't directly affect Abcellera Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.